Natrol

Melatonin 3 mg Time Release

C+
N+ Score74
Sleep & RecoveryServing: 1 Tablet(s)Type: Other Combinations

Natrol Melatonin 3 mg Time Release is a sleep and recovery supplement with a total of 2 ingredients and 100% label transparency. It achieves an N+ Score of 74, receiving a C+ grade, suggesting a good formulation for its intended purpose. This product provides 3mg of Melatonin, commonly used to support sleep, alongside 10mg of Vitamin B6. Research suggests that the 10mg of Vitamin B6 is present at a clinically studied dose, which may contribute to normal neurological function. This supplement may benefit individuals looking for a time-release melatonin option to support sleep cycles.

About This Product

Melatonin 3 mg Time Release by Natrol is a sleep & recovery supplement containing 2 active ingredients. It has earned an N+ Score of 74/100 (Grade C+).

This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.

Notable clinical-dose ingredients include Vitamin B6.

N+ Score Breakdown

Ingredient Adequacy100/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness25/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity65/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Key ingredients at clinically effective doses
  • +Fully transparent label with individual ingredient amounts disclosed
  • +1 ingredient(s) at clinical dose levels

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (2 ingredients)

IngredientAmountDose Adequacy
Vitamin B610.000 mgOptimal
Melatonin3.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.